FDA clears Codexis' new enzyme-making process - Yahoo Finance

(AP) -- Industrial enzyme developer Codexis Inc. said Tuesday that the Food and Drug Administration has approved the company's process for manufacturing the active pharmaceutical ingredient in Merck's diabetes drug Januvia. The news sent shares ...

Merck: Will Singulair Expiration Sink Its Stock? - Seekingalpha.com

Januvia and Janumet are both used to improve control of blood sugar in patients with type II diabetes, which is currently at epidemic stage in the U.S. and is increasing rapidly throughout the developed economies. Isentress is used in combination therapy ...

Merck posts big Q1 profit jump on lower charges - Yahoo Finance

Prescription drug sales rose 3 percent in the latest quarter to $10.08 billion, led by Singulair at $1.34 billion and jumps of about 25 percent for diabetes pills Januvia and Janumet. Together, they brought in $1.31 billion, helping make up for ...

FDA Approves Use of Codexis Enzymes in Merck Manufacturing Process - Seekingalpha.com

the active pharmaceutical ingredient in Merck's Januvia®. FDA approval of this manufacturing process is a major milestone for Codexis, said Peter Strumph, Interim Chief Executive Officer. This is another example of how our directed evolution technology ...

Doctors Group Tells Patients To Go For Cheaper, High-Value Treatments - NPR News

"A month's supply of generic metformin typically costs only about $14 compared with about $230 to $370 for Actos and about $265 for Januvia," the brochure points out. Metformin "lowers blood sugar levels more than newer drugs do," the brochure says.

Novo Nordisk to add 615 jobs - Philadelphia Daily News

The pill Januvia had $3.3 billion of Merck’s $48 billion in total sales in 2011. The most-prescribed pill is the generic metformin, according to IMS Health, a health care information and services company. Amylin Pharmaceuticals and Novo ...

Novo Nordisk, Public Citizen duke it out over Victoza - FiercePharma

The change came after a study showed it outperformed Merck's ($MRK) Januvia at controlling blood sugar and helping patients lose weight. The diabetes market is growing fast, as obesity in the U.S. contributes to rising rates of the disease ...

New treatment for type 2 diabetes stimulus the natural production of insulin - Examiner

Right now he has changed my medication from metformin to Januvia to see if that will help. Perhaps if the new study had been proven effective years ago Montrealers such as myself would have been able to control our diabetes. Researchers from the University ...

EU agency endorses Bristol, Astra diabetes drug - in.news.yahoo.com

Mark Schoenebaum, an analyst at ISI Group, said the news was a positive surprise but might not transform commercial prospects for dapagliflozin, which will compete with other effective oral diabetes drugs, including Merck & Co's Januvia. "While a ...

What Could Move the Markets Today - msnbc.com

Bolstering Merck's revenue were its diabetes drugs, Januvia and Janumet, which grew their sales more than 20% and now account for more than 10% of Merck's revenue. And like Pfizer, Merck looks to its drug pipeline, which includes odanacatib ...